Introduction
Pneumocystis jirovecii pneumonia (PcP) is a common and potentially lethal disease in immunocompromised patients Several lines of evidence suggest that the major factor contributing to morbidity and mortality of PcP patients appears to be the host infl ammatory response to infectious organism rather than the organism itself [4 -8] , although underlying disorders responsive for the impaired immune function are of clinical importance. Compared with non-AIDS PcP patients, signifi cantly greater pathogens and fewer neutrophils or infl ammatory cells associated with less severe lung infl ammation were reported in bronchoalveolar lavage fl uid (BALF) of PcP patients with AIDS [4] . Accordingly, the profi les of cytokines in BALF may be different between PcP patients with and without AIDS.
To the best of our knowledge, the studies on cytokine profi les in BALF of PcP patients with or without AIDS were limited and most studies focused on the pro-infl ammatory cytokines including interleukin-1 (IL-1), IL-6, IL-8 and tumor necrosis factor-α (TNF-α ) [9] . In this study, we liked to measure pro-infl ammatory and anti-infl ammatory cytokines in BALF and to explore their clinical relevance in particular in non-AIDS PcP patients.
Materials and methods

Non-AIDS PcP patients
Thirty-six consecutive non-AIDS patients with PcP diagnosed by identifi cation of Pneumocystis jirovecii (PJ) cysts or trophozoites with Papanicolaous and Gomori methenamine silver stained-smears of BALF at Taipei Veterans General Hospital from November 1987 to February 2009. Patients with concomitant cytomegalovirus pneumonia and/or co-infections with other pathogens including virus, bacteria, mycobacteria and fungus detected by BALF cytological smears and/or culture of BALF were excluded. Peripheral blood samples were collected after BAL for measurements of cytokines. The institutional Review Board of Taipei Veterans General Hospital approved the study, and informed consent was obtained from the patients for the study of cytokines in BALF and blood.
Oxygenation index
The arterial oxygen tension (PaO 2 ) was analyzed with ABL III (Radiometer, Copenhagen, Denmark). Oxygenation index (PaO 2 /FiO 2 ratio) was calculated as PaO 2 divided by inspired oxygen fraction (FiO 2 ). When the data of PaO 2 / FiO 2 was not available, the patients were categorized as requirement for oxygen therapy or not.
BALF and blood samples
The fi beroptic bronchoscope (Model BF20 or P20; Olympus, Tokyo, Japan) was wedged in the orifi ce of a lobar or segmental bronchus of the right middle lobe or lingular division or other appropriate location. Diagnostic BAL was performed using three aliquots of a 50-ml sterile isotonic sodium chloride. Aspirates were pooled into a siliconized container and kept on ice during transport. Part of the retrieved BALF was subjected to Papanicolaou and Riu ' s staining routinely. Some slides were stored for subsequent special staining if clinically indicated. A 10-ml sample of venous blood was drawn immediately after BAL. The supernatant of blood and BAL fl uid were frozen and stored at Ϫ 70 ° C until analyzed.
BALF cell analysis
BALF for cell analysis was fi ltered through sterile gauzes to remove mucus, and then cellular materials were sedimented by centrifugation (2500 rpm for 10 min at 4 ° C) and the supernatant was stored at Ϫ 70 ° C for cytokine analysis later. The pellet was re-suspended in 1 ml PBS for quantitative cell count. The cell differentials of BALF were measured by a hemocytometer (Hausser Scientifi c, Horsham, PA, USA) for counting at least 200 cells. For analysis of lymphocyte subpopulations 200 μ l of cell suspensions (2 ϫ 10 6 cells) were incubated for 40 min at 4 ° C with 20 ml fl uorescein isothiocyanate conjugated monoclonal antibody (Becton Dickinson, San Jose, CA, USA). Following the incubation, 2 ml of cold phosphate buffered saline (PBS) was added to the pellet and washed at 2500 rpm for 10 min at 4 ° C. Prepared BALF samples were examined by fl ow cytometry (FACS Calibur, Becton Dickinson, San Jose, CA, USA)
Measurement of cytokines
The levels of cytokines in the supernatants of BALF and blood were measured by the commercially available enzyme-linked immunosorbent assay kits: IL-1 β , TNF-α , IL-8, monocyte chemoattractant protein-1 (MCP-1), IL-6, IL-10 and transforming growth factor-β 1 (TGF-β 1) (R & D Systems; Minneapolis, MN, USA). The lower limits of these variables were adapted as follows: IL-1 β , 1 pg/ml; TNF-α , 4.4 pg/ml; IL-6, 0.7 pg/ml; IL-10, 3.9 pg/ml; IL-8, 3.5 pg/ml; MCP-1, 5.0 pg/ml; TGF-β 1, 4.61 pg/ml.
Control group
To serve as controls, BALF specimens obtained from 25 subjects without pulmonary abnormality as evidenced by chest radiography, high-resolution computed tomography (HRCT) of the chest and pulmonary function testing including ventilatory function and pulmonary diffusing capacity measured by single breath carbon monoxide. They were healthy subjects in 7, sicca syndrome in 6, uveitis in 9, and sarcoidosis involved eyes only in 3. For blood specimens, only the data obtained from seven normal MCP-1/TGF-β 1 ratio, IL-8/TGF-β 1 ratio and IL-6/TGF-β 1 were signifi cantly higher in PcP patients than in controls. The blood levels of IL-10, TGF-β 1, IL-8, IL-6 and MCP-1 were signifi cantly higher in PcP patients than in controls. However, blood levels of IL-8/TGF-β 1 ratio were signifi cantly higher in controls.
Comparisons of cytokines and pro-infl ammatory/ anti-infl ammatory cytokine ratio among the PcP patients divided into groups by the underlying diseases causing immune impairment
Comparisons among PcP patients who were divided into four subgroups based on the underlying diseases are shown in Table 4 . Age was signifi cantly younger in patients with hematologic disease group than in the other three groups. BALF levels of cytokines and ratios of various infl ammatory cytokine/anti-infl ammatory cytokine did not show any signifi cant differences among the four groups. Blood levels of IL-8 and IL-8/IL-10 ratio were signifi cantly higher in autoimmune disease group than in other three groups. After stepwise logistic regression, age and blood IL-8 still showed statistical signifi cance. Table 5 . subjects were used because infl ammatory changes as shown in peripheral blood could not be totally excluded in those with sicca syndrome, uveitis or eye sarcoidosis.
Statistical analysis
Data were expressed as mean and SD or median and interquartile range (IQR), where appropriate. Non-parametric tests were used to analyze the variables because most of them were not normally distributed. The correlations between variables were determined by Spearman rank correlation coeffi cients. Comparisons of the variables in patients with PcP who were subdivided into two groups based on the variables including oxygenation index, the use of ventilator or survivor status were made using the Mann-Whitney U test. Comparisons of the variables in patients with PcP who were divided into four subgroups based on the underlying diseases were made using Kruskal-Wallis test. Multivariate analysis was performed by stepwise logistic regression. Categorical variables between groups were examined using χ 2 method and/or Fisher ' s exact test, when appropriate. Signifi cance was defi ned as P Ͻ 0.05. Statistical analysis was performed using SPSS version 13 (SPSS, Chicago, IL, USA).
Results
Demographic characteristics, clinical features and cell profi les in BALF
The demographic characteristics and clinical data of 36 non-AIDS patients with PcP are shown in Table 1 . The total cell count and cell differentials, and lymphocyte subpopulations in BALF are shown in Table 2 . Compared with controls, PcP patients had signifi cantly higher lymphocytes in percentage, signifi cantly higher neutrophils either in cell count and percentage, and CD4 cells in percentage, but had signifi cantly lower macrophages in percentage and CD4/CD8 ratio.
Comparisons of BALF and blood cytokines between PcP patients and controls
Of the 36 PcP patients, BALF IL-10 could not be detected in 20 patients. The blood TNF-α in control group was not measured in this study because of being undetectable based on our previous experience. The blood IL-1 β was not measured because of being undetectable or extreme low levels based on our previous experience. Comparisons of cytokines in BALF and blood samples between PcP patients and controls are shown in Table 3 . The levels of BALF IL-10, TGF-β 1, IL-1 β /TGF-β 1, and TNF-α /TGF-β 1 showed no signifi cant difference between PcP patients and controls. In contrast, the values of BALF IL-1 β , MCP-1, IL-6, TNF-α , IL-8, IL-1 β /IL-10 ratio, MCP-1/IL-10 ratio, TNF-α /IL-10 ratio, IL-8/IL-10 ratio, IL-6/IL-10 ratio, Compared to the patients with PaO2/FiO2 Ͼ 200 mmHg, those with PaO2/FiO2 Ͻ 200 mmHg had signifi cantly higher BALF levels of IL-8, IL-8/IL-10 ratio and IL-8/ TGF-β 1 ratio, and had signifi cantly higher blood levels of IL-8 and IL-8/IL-10 ratio.
Compared with PcP patients without ventilator, BALF levels of IL-8 were signifi cantly higher in PcP patients with ventilator. BALF IL-8/IL-10 ratio, IL-8/TGF-β 1 ratio, IL-1 β /TGF-β 1 ratio and MCP-1/TGF-β 1 ratio were signifi cantly higher in PcP patients with ventilator (Table 6 ).
Similar fi ndings could be found in PcP patients who were divided into subgroups by clinical outcome. Compared with survivors, the non-survivors had signifi cantly higher BALF values of IL-8, IL-8/IL-10 ratio, IL-8/TGF-β 1 ratio, IL-1 β /IL-10 ratio, IL-1 β /TGF-β 1 ratio and MCP-1/TGF-β 1 ratio (Table 7) .
Discussion
Our results indicated that compared with control group, PcP patients had signifi cantly higher BALF levels of IL-1 β , TNF-α , IL-6, IL-8 and MCP-1 and signifi cantly higher blood levels of IL-10, TGF-β 1, IL-8, IL-6 and MCP-1 and signifi cantly lower blood levels of IL-8/TGF-β 1. For PcP patients, BALF levels of IL-8, IL-8/IL-10 ratio and IL-8/ TGF-β 1 ratio and blood levels of IL-8 and IL-8/IL-10 ratio were signifi cantly higher in the patients with PaO2/ FiO2 Ͻ 200 mmHg than in those with PaO2/FiO2 Ն 200 mmHg. Similarly, signifi cantly high BALF levels of IL-8, IL-8/IL-10 ratio, IL-1 β /IL-10, IL-1 β /TGF-β 1 ratio, MCP-1/ TGF-β 1 ratio and IL-8/TGF-β 1 ratio were found in the patients requiring mechanical ventilation and in non-survivors. In summary, an imbalance of pro-infl ammatory and anti-infl ammatory cytokines in BALF was found in PcP of non-AIDS immunocompromised patients. BALF levels of IL-8, IL-8/IL-10 ratio, IL-1 β /IL-10, IL-1 β /TGF-β 1 ratio, MCP-1/TGF-β 1 ratio and IL-8/TGF-β 1 ratio may be of value in assessing the severity of PcP and in predicting the outcome of the patients.
The studies on systemic and local pro-infl ammatory and anti-infl ammatory cytokines in non-AIDS patients with PcP are limited. The results on BALF levels of IL-6 in PcP patients are controversial. In the present study, we demonstrated that BALF levels of IL-6 were signifi cantly higher in non-AIDS PcP patients than in control subjects, but failed to show the clinical relevance of the fi ndings. Perenboom et al . [10] demonstrated that the levels of BALF and serum IL-6 were low during acute stage in 10 non-AIDS PcP patients. The results of Iriart et al . [11] indicated that BALF levels of IL-6 were signifi cantly higher in immunocompromised patients with PcP than in immunocompromised patients without PcP and than in the immunocompetent patients without PcP. The discrepancy between our and previous studies may be explained in part by the differences in the immunological status of PcP patients studied, varying degrees of disease severity and different disease course of PcP. Of note, four of 10 patients with non-AIDS PcP patients had concomitant infections in the study conducted by Perenboom et al . [10] . In contrast, non-AIDS patients with concurrent PcP and other infections were excluded in the present study. Furthermore, Iriart and co-workers did not evaluate the clinical importance of BALF IL-6 in non-AIDS PcP patients [11] . Up to date, there are few studies on the clinical relevance of BALF levels of infl ammatory and anti-infl ammatory cytokines in non-AIDS patients with PcP. Tasaka et al . [3] reported that BALF levels of IL-6 and IL-8 were correlated positively with the proportion of neutrophils in BALF and inversely correlated with the oxygenation index in patients with PcP. BALF levels of IL-8 were reported to be related to the severity of PcP and prognosis of PcP patients [6, 12] . In agreement with previous reports, the present study indicated that BALF levels of IL-8 were found to be signifi cantly higher in non-AIDS PcP patients who were prone to have poorer oxygenation index, to require assisted ventilator, and to have higher mortality (Tables 5 -7 ). In addition, signifi cantly higher blood levels of IL-8 were found in non-AIDS PcP patients with poorer oxygenation (Table 5 ). At variance with previous report [3] , our results did not show any correlation between BALF values of IL-6 and neutrophils either in proportion or in absolute cell count in non-AIDS PcP patients (data not shown). The difference in the underlying diseases of the studied subjects and severity of PcP may explain in part.
Increased MCP-1 concentration was shown during Pneumocystis infection either in cell line or animal model studies [13 -16] . One previous study [3] indicated that PcP patients had signifi cantly higher values of BALF MCP-1 than did control subjects, and signifi cantly higher BALF levels of MCP-1 were found in PcP patients without than in those with AIDS. In agreement with the previous study, our results indicated that BALF levels of MCP-1 were Data are expressed as median and IQR (25%;75%). PaO2/FiO2, arterial oxygen tension/fraction of inspired oxygen; BALF, bronchoalveolar lavage fl uid; PcP, Pneumocystis jirovecii pneumonia; IL, interleukin; TGF-β 1, transforming growth factor-β 1; TNF-α , Tumor necrosis factor-α ; MCP-1, monocyte chemoattractant protein-1. The comparisons were made by Mann-Whitney U test. Downloaded from https://academic.oup.com/mmy/article-abstract/51/7/704/979760 by guest on 10 March 2019 signifi cantly higher in non-AIDS PcP patients than in control subjects, however, we failed to show the clinical relevance of BALF levels of MCP-1 in assessing the severity and outcome of PcP in non-AIDS immunocompromised patients. Further studies with larger populations are needed to verify the clinical relevance of BALF MCP-1 in PcP patients with or without AIDS. To the best of our knowledge, the studies on the clinical relevance of anti-infl ammatory cytokines in human PcP have been limited. IL-10 appears to play a pivotal role in modulating the balance between pathology and protection [17] . One animal study using IL-10 knockout mice demonstrated that IL-10 could down-regulate immune response to Pneumocystis infection [18] . Another study reported that gene transfer of viral IL-10 to murine lungs could suppress infl ammatory responses to P neumocystis infection without infl uencing the intensity of infection [19] . TGF-β is also a well known anti-infl ammatory cytokine [20, 21] . Angelici et al demonstrated that increased total production of TGF-β by peripheral blood monocytes was observed in immunocompromised patients with PcP infection, but the functional activity of TGF-β was markedly suppressed [22] .
Similar fi ndings were reported in a rat study to investigate alveolar lining fl uid concentrations of active form and total amount of TGF-β in rat Pneumocystis carinii pneumonia [23] . Iriart and co-workers demonstrated that BALF levels of IL-10 and TGF-β showed no signifi cant differences between the patients with and without PcP [11] . In keeping with previous study, the present study indicated that BALF levels of IL-10 and TGF-β 1 showed no signifi cant difference between non-AIDS PcP patients and control subjects (Table 3) . However, signifi cantly higher levels of blood IL-10 and TGF-β 1 were found in non-AIDS patients with PcP. The increased blood levels of anti-infl ammatory cytokines seem parallel with an increase of blood values of infl ammatory cytokines including IL-6, IL-8 and MCP-1 as shown in the present study (Table 3) .
To the best of our knowledge, the balance of proinfl ammatory and anti-infl ammatory cytokines and its clinical relevance in PcP patients have not yet been well investigated. In this study, we demonstrated that an imbalance of pro-infl ammatory and anti-infl ammatory cytokines in BALF did occur in PcP of non-AIDS patients (Table 3) . Furthermore, except for IL-8 BALF levels of pro-infl ammatory or anti-infl ammatory cytokines had limited value in assessing the severity of PcP and in predicting the outcome of non-AIDS PcP patients. In contrast, BALF IL-8/IL-10 ratio, IL-8/TGF-β 1 ratio, IL-1 β /IL-10 ratio, IL-1 β /TGF-β 1 ratio and/or MCP-1/TGF-β 1 ratio were of considerable value in assessing severity of PcP and in predicting the outcome of non-AIDS PcP patients. Non-AIDS PcP patients with signifi cantly higher BALF values of IL-8/IL-10 ratio, IL-8/ TGF-β 1 ratio, IL-1 β /IL-10 ratio, IL-1 β /TGF-β 1 ratio and/ or MCP-1/TGF-β 1 ratio were prone to have poorer oxygenation, to develop respiratory failure requiring ventilator support and to die (Tables 5 -7) . This is the fi rst study to show the clinical importance of the balance of pro-infl ammatory and anti-infl ammatory cytokines in PcP of non-AIDS immunocompromised patients. Further studies with larger populations are needed to verify these issues. The study has some limitations. First, we did not include AIDS PcP patients. Because the outcome of PcP in AIDS patients is better than in those without AIDS, the study on non-AIDS PcP patients is of more clinical importance. Second, we did not include immunocompromised patients without PcP, PcP patients without immunocompromised status and immunocompromised patients with non-Pneumocystis pneumonia to serve as the disease control groups. The data obtained from these subjects may be of value in helping to elucidate the role of pro-infl ammatory and antiinfl ammatory cytokines in PcP patients. Third, some infl ammatory and anti-infl ammatory cytokines were not investigated in this study. Fourth, the function of regulatory T cells and IL-17 were not explored in this study. However, the most common pro-infl ammatory and anti-infl ammatory cytokines were evaluated in the present study. Despite of some limitations, the results of present study may be of clinical relevance. An imbalance of pro-infl ammatory and anti-infl ammatory cytokines in BALF did occur in PcP of non-AIDS immunocompromised patients. In addition, the imbalance of pro-infl ammatory and anti-infl ammatory cytokines in PcP as shown by BALF levels of IL-8/IL-10 ratio, IL-8/TGF-β 1 ratio, IL-1 β /IL-10 ratio, IL-1 β /TGF-β 1 ratio and/or MCP-1/TGF-β 1 ratio were of value in assessing the severity of PcP and in predicting the outcome of the patients.
In summary, an imbalance of pro-infl ammatory and anti-infl ammatory cytokines in BALF does occur in PcP of non-AIDS immunocompromised patients. BALF levels of IL-8, IL-8/IL-10 ratio, IL-1 β /IL-10 ratio, IL-1 β /TGF-β 1 ratio, MCP-1/TGF-β 1 ratio and IL-8/TGF-β 1 ratio may be of value in assessing the severity of PcP and in predicting the outcome of non-AIDS PcP patients.
